The Efficacy of Metronidazole , Amoxicilin, Bismuth, Omeprazole – (OMAB) Based Quadruple Therapy for Eradication of Helicobacter Pylori Infection in Hamedanian Patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138901213676N1

Enrollment

100

Registered

2010-05-11

Start date

2010-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer disease. Peptic ulcer, Deudenal ulcer, Gastritis

Interventions

OMAB Regime, Omeprazole20mg- metronidazole 500mg-amoxicillin1000mg-bismuth240mgtwice daily for2weeks then omeprazole20mg for 4weeks.

Treatment - Drugs

OMAB Regime, Omeprazole20mg- metronidazole 500mg-amoxicillin1000mg-bismuth240mgtwice daily for2weeks then omeprazole20mg for 4weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with peptic ulcer symptoms who need Endoscopy based on history an physical exam entered into this study. Exclusion criteria: antibiotic consumption in recent month; proton pump inhibitory drug or Bismut in recent 2 weeks or bleeding or any contradiction to endoscopy. In case of existing tumour in Endoscopy and not completing treatment, patients were also excluded

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
?Helicobacter pylori infection. Timepoint: 6 weeks after treatment. Method of measurement: Urea breathing test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Reza Tavakoli

Hamedan university of medical sciences

mr.tavakoli@umsha.ac.ir+98 81 1838 0286

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026